Department of Rehabilitation Medicine, Affiliated TaiHe Hospital of Hubei University of Medicine, Shiyan, 442000 Hubei, China.
Department of TCM Rehabilitation Medicine, Affiliated Foshan Gaoming Hospital of Guangdong Medical University, Foshan, 528000 Guangdong, China.
Biomed Res Int. 2022 Sep 22;2022:1761434. doi: 10.1155/2022/1761434. eCollection 2022.
Neck pain is one of the most common musculoskeletal diseases. Fu's subcutaneous needling therapy is a special acupuncture method that targets muscle trigger points. It has been proven to have a positive effect on the treatment of neck pain. The access to its curative effect may be related to the improvement of muscle and soft tissue condition. The purpose of this study is to evaluate the outcome of Fu's subcutaneous needling therapy for patients with neck pain by collecting changes in the sEMG of the patient's neck muscles and related data from evaluation scales and explore the feasibility and safety of Fu's subcutaneous needling therapy for neck pain.
72 patients meeting the inclusion criteria were randomly divided into FSN group and acupuncture group for corresponding treatment. FSN group was treated once every other day for 5 consecutive treatments; the acupuncture group was treated once a day for 10 consecutive treatments.
Outcome indicators were measured at baseline, after the first treatment and the end of the treatment. Primary outcome indicators: average EMG (AEMG) and (mean power frequency) MPF of sternocleidomastoid muscle and superior trapezius muscle. Secondary outcome indicators: Mc Gill pain questionnaire (MPQ), neck disability index (NDI), and adverse reactions.
This study will explore the efficacy, safety, and possible mechanism of Fu's subcutaneous needling therapy for patients with neck pain, thus to provide more evidence support for clinical decision-making. This trial is registered with Chinese Clinical Trial Register Center (registration number ChiCTR2100043529).
颈痛是最常见的肌肉骨骼疾病之一。浮针疗法是一种针对肌筋膜触发点的特殊针刺方法,已被证明对颈痛的治疗有积极作用。其疗效的获得可能与改善肌肉和软组织状况有关。本研究旨在通过收集患者颈部肌肉的表面肌电图(sEMG)变化及相关评估量表数据,评估浮针疗法治疗颈痛患者的疗效,并探讨浮针疗法治疗颈痛的可行性和安全性。
纳入符合标准的 72 例患者,随机分为浮针组和针刺组进行相应治疗。浮针组隔日治疗 1 次,连续治疗 5 次;针刺组每日治疗 1 次,连续治疗 10 次。
在基线、首次治疗后和治疗结束时测量结局指标。主要结局指标:胸锁乳突肌和斜方肌的平均肌电图(AEMG)和(平均功率频率)MPF。次要结局指标:麦吉尔疼痛问卷(MPQ)、颈痛残疾指数(NDI)和不良反应。
本研究将探讨浮针疗法治疗颈痛患者的疗效、安全性及可能的作用机制,为临床决策提供更多证据支持。本试验在中国临床试验注册中心注册(注册号 ChiCTR2100043529)。